In the last trading session, 7.31 million Oscar Health Inc (NYSE:OSCR) shares changed hands as the company’s beta touched 1.84. With the company’s per share price at $16.47 changed hands at -$0.28 or -1.67% during last session, the market valuation stood at $4.19B. OSCR’s last price was a discount, traded about -44.44% off its 52-week high of $23.79. The share price had its 52-week low at $11.20, which suggests the last value was 32.0% up since then.
Analysts gave the Oscar Health Inc (OSCR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.62. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended OSCR as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Oscar Health Inc’s EPS for the current quarter is expected to be 0.48.
Oscar Health Inc (NYSE:OSCR) trade information
Instantly OSCR was in red as seen at the end of in last trading. With action -2.66%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 22.54%, with the 5-day performance at -2.66% in the red. However, in the 30-day time frame, Oscar Health Inc (NYSE:OSCR) is 41.49% up.
The consensus price target for the stock as assigned by Wall Street analysts is 21, meaning bulls need an upside of 21.57% from its current market value. According to analyst projections, OSCR’s forecast low is 5 with 28 as the target high. To hit the forecast high, the stock’s price needs a -70.01% plunge from its current level, while the stock would need to tank 69.64% for it to hit the projected low.
Oscar Health Inc (OSCR) estimates and forecasts
Year-over-year growth is forecast to reach 22.50% up from the last financial year.
Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 2.84B. 7 analysts are of the opinion that Oscar Health Inc’s revenue for the current quarter will be 2.79B. The company’s revenue for the corresponding quarters a year ago was 2.22B and 2.42B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 27.98%. The estimates for the next quarter sales put growth at 14.93%.
The 2025 estimates are for Oscar Health Inc earnings to increase by 637.55%, but the outlook for the next 5-year period is at 166.36% per year.
OSCR Dividends
Oscar Health Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 5.9391% or 14.18 million shares worth $224.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and SMALLCAP WORLD FUND INC . With 6.14 shares estimated at $101.1 million under it, the former controlled 2.80% of total outstanding shares. On the other hand, SMALLCAP WORLD FUND INC held about 2.76% of the shares, roughly 6.05 shares worth around $99.57 million.
